The Compound Action Potential in Subjects Receiving a Cochlear Implant by Scott, William C. et al.
The Compound Action Potential in Subjects Receiving a 
Cochlear Implant
William C Scott, BA1, Christopher K Giardina, BS1, Andrew K Pappa, BS1, Tatyana E 
Fontenot, MD1, Meredith L Anderson, AuD1, Margaret T Dillon, AuD1, Kevin D Brown, MD, 
PhD1, Harold C Pillsbury, MD1, Oliver F Adunka, MD1,2, Craig A Buchman, MD1,3, and Doug 
Fitzpatrick, PhD1
1Department of Otolaryngology - Head and Neck Surgery, University of North Carolina, Chapel 
Hill, NC, USA
2Department of Otolaryngology - Head and Neck Surgery, The Ohio State University, Columbus, 
OH, USA
3Department of Otolaryngology - Head and Neck Surgery, Washington University School of 
Medicine in St Louis, St Louis, MO, USA
Abstract
Hypothesis—The compound action potential (CAP) is a purely neural component of the 
cochlea’s response to sound, and may provide information about the existing neural substrate in 
cochlear implant (CI) subjects that can help account for variance in speech perception outcomes.
Background—Measurement of the ‘total response’ (TR), or sum of the magnitudes of spectral 
components in the ongoing responses to tone bursts across frequencies, has been shown to account 
for 40–50% of variance in speech perception outcomes. The ongoing response is composed of 
both hair cell and neural components. This correlation may be improved with the addition of the 
CAP.
Methods—Intraoperative round window electrocochleography (ECochG) was performed in adult 
and pediatric CI subjects (n=238). Stimuli were tones of different frequencies (250 Hz–4 kHz) at 
90 dB nHL. The CAP was assessed in two ways, as an amplitude and with a scaling factor derived 
from a function fitted to the response. The results were correlated with CNC word scores at 6 
months post-implantation (n=51).
Results—Only about half of the subjects had a measurable CAP at any frequency. The 
consonant-nucleus-consonant (CNC) word scores correlated weakly with both amplitude (r2=0.20, 
p < 0.001) and scaling factor (r2=0.25, p < 0.01). In contrast, the TR alone accounted for 43% of 
the variance, and addition of either CAP measurement in multiple regression did not account for 
additional variance.
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Conclusions—The underlying pathology in CI patients causes the CAP to be often absent and 
highly variable when present. The TR is a better predictor of speech perception outcomes than the 
CAP.
Introduction
There is a wide range of speech perception outcomes in patients with cochlear implants 
(CIs). Many factors have been shown to influence these outcomes, including duration of 
deafness, age, and audiometric and surgical factors1–4. However such factors have only been 
shown to account for a small amount of the variability among patients, typically less than 
20% for single factors and only slightly increased with multiple variables included. A factor 
that may help explain more of the variability is residual cochlear physiology. Given that 
cochlear implants function by stimulating residual neural elements, it is intuitive that having 
more surviving nerve fibers should lead to improved outcomes. However, this intuition has 
generally not been confirmed by the literature. Most anatomic studies that have counted 
spiral ganglion cells post-mortem have shown no correlation or even negative correlation 
between surviving nerve fibers and speech perception5–8. An exception is a recent study that 
showed a positive correlation between SCG counts and outcomes in six bilaterally implanted 
patients9.
Evidence for the influence of residual cochlear physiology on speech perception has recently 
come from electrocochleography (ECochG). Using ECochG, the electrical response of the 
cochlea to sound can be recorded prior to implantation. Measurements of the “total 
response” (TR), accounted for 40–50% of variance in speech recognition outcomes at 6 
months10,11. The TR is the sum of the spectral magnitudes of the ongoing, or steady-state, 
response to a series of tone bursts of different frequencies. A limitation is that TR does not 
discriminate between hair cell (cochlear microphonic, or CM) and neural responses 
(auditory nerve neurophonic, or ANN) that are combined in the ongoing response. The 
major aim of this study was to determine if the compound action potential (CAP), a purely 
neural response, can be used to improve the ability of ECochG to account for variance in 
speech perception across subjects.
The CAP is the product of the summed, synchronous firing of action potentials from 
auditory nerve fibers in response to the onset or offset of a signal12–14. It is a purely neural 
potential, unlike the TR. Earl and Chertoff15 demonstrated in gerbils that by fitting a 
modeled CAP that includes a scaling parameter reflecting neural survival to measured CAPs, 
it was possible to predict the extent of experimentally induced damage to the auditory nerve 
more accurately than if they measured the CAP amplitude alone. For the present study, we 
evaluated different ways to measure the CAP following intraoperative recording in CI 
subjects, including the analytic method of Earl and Chertoff (2010), in both children and 
adults. We then correlated these measures to consonant-nucleus-consonant (CNC) word 
scores 6-month post-implantation in adult CI subjects, both alone and in combination with 
the TR.
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Materials and Methods
All pediatric and adult CI candidates at the study institution were potential subjects. Non-
English speaking subjects, subjects undergoing revision surgery, and subjects with 
malformed cochlear anatomy were excluded. The procedures were in accordance with the 
ethical standards of the study site’s institutional review board, and informed consent was 
obtained for all subjects before implantation (UNC Protocol No. 05-2616).
ECochG to acoustic stimuli was recorded intraoperatively from the round window (RW) just 
before electrode array insertion. Because the CAP has not been previously studied in the 
general population of CI subjects, the first step was to characterize and develop methods to 
quantify the CAP across adult and pediatric subjects (n=242, 112 adults and 130 children). 
The relationship between the CAP and postoperative speech perception outcomes was then 
evaluated in adult subjects with word score outcomes (n=54).
Surgery and Recording Setup
Cochlear implantation was performed by four neurotologists at the study institution. Before 
incision, surface electrodes were placed on the forehead and the contralateral mastoid, and a 
sound tube attached to a foam insert was placed in the ear canal. A standard transmastoid 
facial recess approach was used to access the cochlea. Once the RW niche was visible in the 
surgical field, a sterile monopolar probe (Neurosign, Magstim Co, Wales, UK) was placed 
adjacent to the RW membrane. All included recordings had impedances below 16 kOhms on 
each electrode. Acoustic stimuli were delivered from an Etymotic ER-3b speaker. 
Recordings took 5–10 minutes of surgical time prior to array insertion.
Stimulation and Recording
A Bio-logic Navigator Pro (Natus Medical, Inc., San Carlos, CA) generated acoustic stimuli 
and recorded electrophysiological signals. Saline was introduced into the RW niche to 
reduce impedance in some cases. Stimuli were tone bursts (250, 500, 750, 1000, 2000, and 
4000 Hz), alternating in condensation and rarefaction starting phases, with up to 250 
repetitions of each phase. In cases with large responses, fewer averages were often used. 
Rise/fall times were one cycle or 1 ms, whichever was longer, shaped by a Blackman 
window. Plateau durations were 20 ms (250–750 Hz), 10 ms (1000 and 2000 Hz) or 5 ms 
(4000 Hz). Recording epochs were 32 ms (250–2000 Hz) or 10.66 ms (4000 Hz). The high-
pass filter setting was 10 Hz, and low-pass setting were 5000 Hz (250–1000Hz), 10000 Hz 
(2 kHz) or 15,000 Hz (4 kHz). Stimulation rates were 17.3 (250–2000 Hz) or 23.3 (4000 Hz) 
per sec. All stimuli were presented at 90 dB nHL (87–107 dB SPL depending on frequency).
Data Analysis
The data from condensation and rarefaction phases were stored separately. An average 
‘difference’ trace was determined by subtracting, and a ‘sum’ trace by adding, the response 
to the condensation and rarefaction phases and dividing by 2. The TR from each case 
represents the magnitude of the fast Fourier transform (FFT) of the stimulus frequency and 
its harmonics during the ongoing portion of the response, summed across stimulus 
frequencies. Each response peak was considered significant if it exceeded the noise level by 
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3 standard deviations. The noise and its variance were determined from 6 bins, 3 on each 
side of the signal starting 2 bins away from the peak.
The sum tracing was used for all CAP measurements. First, the CAP amplitude was 
measured as a negative deviation from a baseline, and was considered significant if the first 
negative deflection (N1) was below both the baseline and the ongoing response by more than 
3 standard deviations. For this measurement, filters and windows often needed to be 
adjustable as the latency and morphology of the CAP varied considerably. Even with the 
addition of flexible filters and windows, the morphology of the CAP varied enough that 
many cases were resistant to this objective analysis. In cases where a CAP was visually 
present but not objectively detected the CAP was measured with a cursor as the maximum 
deviation from the pre-response baseline. For 250 Hz a CAP was difficult to detect either 
automatically or visually, so this frequency was not used in the CAP measurement.
The second measurement technique was based on a model (Eq. 1) developed by Goldstein 
and Kiang13, which represents a convolution of the single unit response waveform U(t) and 
the probability density function P(t) of firing in a population of nerve fibers whose size is 
represented by the scaling factor N. Functional equations for U(t) and P(t) were developed 
by Chertoff14 and are shown in equations 2 and 3. The single unit response waveform, U(t), 
is modeled as a decaying sine wave where k represents rate of decay and f represents 
oscillation frequency of the wave. The probability density function, P(t), is written as a 
gamma function, where β governs the width of the density function and α represents delay 
after stimulus onset. Time in ms is represented by t, γ is a constant with a value of 2, and 
ω=2π f. Nonlinear regression (MATLAB, NLINFIT) was used to model the CAP using the 
convolution equation 1-yielding a fitted CAP. Once a best-fit was obtained, the parameter of 
most interest was the scaling factor N. In many cases, the original sum tracing required a 
smoothing function (triangular smooth over one period of the stimulus frequency was used) 
for the regression to be successful. An R2 value was obtained for each fitted CAP. A fit with 
an R2 value of 0.75 or greater was considered acceptable.
Eq 1
Eq 2
Eq 3
The CAP amplitudes and scaling factor N were summed across all frequencies where CAP 
was present to give a “total CAP amplitude” (TCA) and “total N’ (TN).
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Speech Perception
The CNC word test consists of phonemically balanced monosyllabic words and was 
administered as part of the speech perception assessment by audiologists. It was scored as a 
percent correct out of 50 words, and the results 6 months after CI activation was the 
outcomes measure. Because it consists of isolated words, the CNC word test is typically 
more difficult than other speech perception measures, reducing ceiling effects16. The test 
was administered in the sound field, with the subject in a sound-isolated booth facing the 
speaker at 0° azimuth. Lists were presented at 60 dB SPL.
Statistics
Single and multiple linear regression was performed using IBM SPSS Statistics 23.
Results
Figure 1 shows an example of a case with a CAP and the measurement methods used. The 
responses to condensation and rarefaction phases (Figure 1A) show a prominent CAP 
(circled). The sum of the responses (Figure 1B) removes those components that change with 
the phase of the stimulus, which includes most of the CM but little of the CAP in most 
cases. Thus, the sum waveform was used for all measurements. The largest portion and often 
the only part of the CAP was typically the first deflection below the baseline, so the N1 was 
taken as the CAP amplitude. The fitted CAP, used to determine N (Eq. 1), is also shown 
(arrow).
In general the CAPs had a highly variable morphology (Fig. 2). A major difficulty was that 
the CAPs were often partially obscured by the CM and/or the summating potential (SP, 
Figure 2A–2E). Because the modeling equation is based on a decaying sine wave, cases 
where the CAP took a different form proved challenging and sometimes impossible for the 
regression algorithm (Figure 2E, F). In 15 cases, CAP amplitude could be measured but it 
was not possible to obtain an “N” value with an R2 above our acceptable threshold using the 
model.
A CAP was detected to at least one frequency in 50% of subjects (121/242). The CAP was 
slightly more common in adults (56%) than children (46%). In contrast, a significant 
ongoing response was present in almost all cases (>90%). The lack of a CAP was not 
conclusive evidence of the lack of neural responses. Some cases without a CAP showed 
nerve activity in the form of the ANN. The ANN is the evoked correlate of auditory nerve 
phase locking. It produces unique distortion patterns in the ECochG tracing. Figure 3A is an 
example with an absent CAP but a clear ANN based on distortion patterns. The ANN was 
found in 15 subjects that had no discernable CAP.
The remaining 107 cases without evidence of CAP had no evidence of ANN either. Cases 
without CAPs were somewhat more likely to have a small TR. However, there were many 
cases at all levels of TR that did not have a CAP. One example of a case with a large TR but 
no CAP is shown in Figure 3B.
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Correlations of TR, TCA and TN
For comparison with the TR, which is the sum of responses to different frequencies, the 
“total CAP amplitude (TCA)” and “total N (TN)” were determined from the summed 
amplitudes and N values across frequencies for each case. Our two CAP measuring 
methods, the TCA and TN, were highly correlated (Figure 4A, r2 = 0.62 only including 
cases with present CAPs). For cases that had CAPs, their amplitudes and N components 
scaled with the size of the TR (Figure 4B, 3C).
Correlation of TR, TCA and TN with CNC word score test after 6 months
The CNC word scores at 6 months were obtained for 54 adult patients. When plotted against 
TR (Figure 5A), there were 3 cases (grey triangles) that were not included in the correlation 
with outcomes in previous studies10,11 and were also excluded here. These had a large TR 
and considerable indication of neural activity in the form of a CAP and/or ANN, but only 
average speech perception outcomes. The ECochG results suggest the reason for merely 
average performance had little to do with their cochlear physiology (see Discussion). These 
subjects had Meniere’s disease (n=1), auditory nerve spectrum disorder (n=1) and unknown 
(n=1) causes of their hearing loss.
Two cases (x in Figure 5A) that were excluded in previous studies10,11 were included here. 
These cases had a large TR but comparatively little evidence of neural activity, so that the 
large TR might not indicate a strong neural substrate for electrical stimulation. The inclusion 
of a nerve-specific measure like the CAP might prove especially useful in accounting for the 
modest outcome compared with that expected from the TR alone.
In 18 of the 51 cases there was no evidence of an acoustic CAP, but most subjects performed 
well with the implants. Both TCA and the TN parameters had significant positive 
correlations with outcomes based on CNC scores. TN had a stronger correlation with CNC 
score (Figure 5B) than that between TCA and CNC score (Figure 5C). The correlation of TR 
with CNC scores for the same 51 cases was much higher than either of these (Figure 5A). 
Multiple regression using the TR and TCA, or TR and TN did not improve prediction of 
CNC scores over that of TR alone.
Finally, for the adults with CNC scores, the presence or absence of a CAP across the 
different frequencies are tallied as a function of the audiometric thresholds in Table 1. There 
were fewer than 50% of cases with CAPs for all frequencies. There were fewer subjects with 
CAPs when the audiometric thresholds were highest, as might be expected. However, even 
where thresholds were relatively good, i.e. where the hearing loss was mild to severe, only 
about half the subjects had CAPs.
Discussion
Only ~50% of subjects showed evidence of a CAP to any frequency. When present, the CAP 
morphology was extremely variable. Two measurement techniques, TCA and TN, were 
highly correlated with each other but had different strengths in some cases. The lack of a 
CAP in many subjects, its variability when present, and its high correlation with TR 
significantly limited the CAP’s utility in helping to account for speech perception outcomes.
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CAP prevalence in the CI population
About half of CI subjects had no CAP, and yet most subjects in the CNC scores group had a 
measurable TR and did well with their implants. Cases with good outcomes despite no CAP 
or ANN must have nerve fibers that can be electrically stimulated even if they do not 
contribute a response to sound. In this respect the CAP is similar to the audiogram, because 
a behavioral response to sound also requires a functioning chain of hair cell and auditory 
nerve connections, while electrical stimulation requires only ganglion cells. Correlations 
between the audiogram and speech perception outcomes tend to be poor17,18 so a similar 
result for the CAP was not unexpected. The CAP and the audiogram differ in that CAP 
measurements are of magnitude rather than threshold, and because responses to low 
frequencies that lead to behavioral responses may produce relatively poor CAPs due to slow 
rise times that reduce synchrony. This is the reason that finding a CAP to 250 Hz is rare 
(Table 1). In CI subjects the largest responses, and those seen in most subjects, are to 1000 
Hz or lower frequencies10,19. Although outside the scope of this study, the large data set will 
allow for future reports comparing the CAP and other attributes of the ECochG recordings 
for different etiologies of hearing loss in children and adults.
CAP morphology in the CI population
In animal models with normal hearing, the CAP typically has a negative deflection below 
the baseline (N1), followed by a positive deflection (P1), and then possible further 
fluctuations. This pattern is the basis of the modeling equation used here14,21. Few of the 
CAPs in the CI subjects had the “typical” pattern (compare Figures 1 and 2). This 
morphologic variability and the overall dearth of CAPs discussed above can probably be 
largely explained by anatomic and physiologic characteristics of the CI population. The 
CAP depends on the simultaneous firing of many nerve fibers throughout the length of the 
cochlea. In normal hearing cases at high intensities, the CAP is thought to originate 
primarily from the base of the cochlea14, which is the area most heavily damaged in most CI 
subjects22–24. In a study applying the same convolution model used here to humans who 
were noise exposed to cause temporary deafness, the authors found that noise exposed 
subjects had flattening and widening of the CAP complex, and concluded that this reflected 
a temporary loss of synchrony in their subjects’ nerve fibers25. This widening is similar to 
many of the CAPs we observed in our study (examples Fig 2B, 3D). In the case of CI 
subjects, this may reflect some loss of synchrony due to hearing loss, due to slow rise times 
of the low frequency stimuli, and due to the responses originating from the apex where the 
traveling wave slows.
The variable CAP morphology in this population posed challenges when using modeling. In 
particular, CAPs that had very steep rise and fall and CAPs with large positive components 
did not work with the decaying sine wave model of the unit potential used in the convolution 
equation (see Figure 1D and Figure 2E, 2F). Still, most CAPs we observed were 
successfully fitted using the analytic equation.
The ANN as a neural marker
A subset of patients did not have any evidence of CAP but showed direct evidence of nerve 
activity through an observable ANN. In these cases, there was a population of nerve fibers 
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phase-locking to the stimulus that did not respond synchronously enough to form an onset 
CAP. The ANN is present at low frequencies where neurons can phase-lock to the stimulus, 
typically below 1500 Hz26–28. This could give the ANN an advantage as a neural marker in 
CI subjects that have residual hearing at predominantly low frequencies. Unfortunately, it is 
difficult to measure because it forms a mixed response with the CM. At this time there is no 
technique that can cleanly separate the two, and therefore a method to quantify the ANN is 
lacking.
The CAP as a predictor of speech perception outcomes
The N component of the modeled CAP correlated slightly better with outcomes than 
amplitude measurements, cconsistent with Earl and Chertoff’s (2010) findings in 
experimentally deafened gerbils. Amplitude measurements were less predictive of speech 
perception outcomes, but had the advantage of being a simpler measurement that could be 
applied to more cases.
Although the correlations of TCA and TN with outcomes were significant they were weak, 
and the main hope was that any indication of nerve activity could improve the correlation 
over that available from the TR alone. However, when added into multivariate regression 
with the TR neither metric for measuring the CAP improved the correlation. Thus, at this 
time, TR remains the best ECochG metric to predict speech perception outcomes in CI 
subjects.
Why does the TR, consisting of the CM and ANN (when present), account for so much 
more of the outcome variance? Unlike the CAP or audiogram, the CM is a measure of hair 
cell rather than neural health, so it seems counterintuitive that it should better predict 
outcomes than the neural activity itself. We have previously hypothesized that the inclusion 
of these hair cell responses provides an indication of overall cochlear health, and a healthy 
environment may be more likely to support nerve fibers amenable to electrical 
stimulation10,11. The CAP, like the audiogram, excludes information from hair cells.
In principle, the electrically evoked CAP, or eCAP, which is a direct measure of auditory 
nerve elements available for stimulation, should show a better correlation than an indirect 
measure of cochlear health. However, attempts to correlate eCAPs with speech perception 
outcomes have largely failed, showing weaker correlations than the CAPs in this study and 
much weaker correlations than TR.20 A possible reason is the very limited dynamic range 
with eCAPs, compared to the TR, which varies by over 60 dB across subjects.
The prediction of speech recognition outcomes is one of the most promising applications of 
ECochG. Data from EcochG can be used to identify subjects that are performing worse than 
expected based on their residual physiology (such as the “grey triangle” outliers in Fig. 5A). 
This could assist clinicians towards evaluating other potential influences on speech 
perception. However, there are some cases where it has consistently proven challenging to 
interpret ECochG. Cases where the degree of hair cell and neural response do not agree are 
among the most problematic. Finding a way to measure the degree of neural activity in the 
signal should aid the interpretation of ECochG recordings in these subjects. Though the 
CAP alone was not sufficient to define the neural response in ECochG, it may still prove 
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useful in conjunction with other neural markers, like the ANN, as part of a more 
comprehensive measurement.
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Figure 1. Measuring the Compound Action Potential
A. Responses to condensation and rarefaction phase stimuli. The compound action potential 
(CAP) is circled. B. The sum of condensation and rarefaction phases. The “N1”amplitude of 
the CAP is marked by the bracket. The fitted CAP derived from the response is represented 
by the solid black line under the tracing (arrow).
Scott et al. Page 11
Otol Neurotol. Author manuscript; available in PMC 2017 December 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 2. Examples of CAP morphology in CI patients
For each case, the dotted lines indicate the baseline and amplitude measurements, and the 
solid black line is the model fit. A. This response had a well-defined CAP to a low frequency 
(500 Hz). B. This CAP to 500 Hz was obscured by the fine structure of the response. C. This 
apparent CAP was associated with a large summating potential (arrows). D. This CAP was 
shallow and spread in time. E. This CAP was also obscured by a summating potential, which 
was positive in this case. The fitting program was unable to measure this CAP. F. This CAP 
had a prominent P1, or positive, component (x). The fitting program was also unable to 
measure this CAP.
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Figure 3. The presence or absence of an ANN
A. This case had no CAP (sum, bottom left), but had a strong auditory nerve neurophonic 
(ANN), indicated by the distortions in the ‘average cycle; (upper right) and in the FFT 
(bottom right). B. This case had neither CAP (sum, bottom left) nor ANN, as indicated by 
relative lack of distortions (upper right and FFT, lower right)).
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Figure 4. Population data
A. Total CAP Amplitude (TCA) vs. total N (TN). These were highly correlated. B, C. Both 
measurements of the CAP vs. total response (TR). They scaled with total response, but many 
cases had no CAP despite a strong TR.
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Figure 5. Outcomes data
A. TR vs 6-month CNC score. The data points marked by grey triangles and “X” are 
outliers. Those marked by triangles are excluded from the regression analysis, while those 
marked by “X” are included (see text). B. TN vs CNC score. C. TCA vs CNC score.
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